Inventor
Christina KOBER
Inventor
DE
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
12,522,5942-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer202612,478,621Substituted aminoquinolones as dgkalpha inhibitors for immune activation202511,998,539Substituted aminoquinolones as DGKalpha inhibitors for immune activation202411,795,1642-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer202311,591,3113-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides202311,459,312Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to DEUTSCHES KREBSFORSCH (6)· patent assignee history
2022–2025Patents assigned to BAYER AG (5)· patent assignee history
2022–2025Patents assigned to Bayer Pharma AG (5)· patent assignee history
2022–2026Based in DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DEUTSCHES KREBSFORSCH | 6 | 2022–2026 |
| BAYER AG | 5 | 2022–2025 |
| Bayer Pharma AG | 5 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 6 | 2022–2026 |